secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medtronic plc (MDT)
CIK:        0001613103
Form:       8-K
Filed at:   2026-03-24T23:59:59+00:00
Accession:  0001613103-26-000005
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Medtronic cuts FY2026 EPS guidance on MiniMed charges; FDA clears MiniMed Flex pump
--------------------------------------------------------------------------------

- FDA cleared MiniMed Flex insulin pump several months earlier than expected; smartphone-controlled.
- One-time $157M charge in Q4 FY2026 due to Blackstone royalty arrangement; $0.08 EPS impact.
- MiniMed IPO (10% stake) closed Mar 9; dilutes Medtronic EPS by $0.04 in Q4 FY2026.
- FY2026 non-GAAP EPS guidance revised to $5.50-$5.54 from $5.62-$5.66.
- FY2027 high single-digit EPS growth guidance unchanged; Blackstone earns mid-to-high single digit royalty on first two years of net sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1613103/000161310326000005/0001613103-26-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1613103/000161310326000005/mdt-20260324.htm
  HTML page:      https://secwatch.observer/filing/0001613103-26-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer